EU Fast-Track Fail For Another BMS CAR-T Cell Therapy

EMA Review Of Ide-Cel Reverts To Standard Timelines; Orva-Cel Development Program Scrapped

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".